Neurophysiology of Surround Inhibition in the Human Motor Cortex
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03018262|
Recruitment Status : Completed
First Posted : January 12, 2017
Last Update Posted : May 22, 2019
Movement disorders have many different causes and symptoms. Researchers still do not fully understand which parts of the brain are involved in fine movement. They want to learn about which brain regions could be abnormal in people with movement disorders.
To better understand how the brain controls movement.
Healthy, right-handed adults age 18-70 years old.
Participants will be screened with a physical exam and questions about their handedness. They may have a urine test.
Participants will have 1 or 2 clinic visits. The first visit will last about 1.5 hours. The second will last about 3 hours.
Participants will have structural magnetic resonance imaging (MRI). A strong magnetic field and radio waves take pictures of the brain. Participants will lie on a table that slides in and out of a metal cylinder.
Participants may have transcranial magnetic stimulation. A wire coil is held on the scalp. A brief electrical current is passed through the coil and creates a magnetic pulse that stimulates the brain. Participants will wear a pair of glasses or a headband with small sensors so researchers can track head position.
Participants will perform a simple index finger movement task.
Participants may have surface electromyography from at least two hand muscles. Small metal disk or adhesive pad electrodes will be taped to the skin. Participants will be seated in a comfortable chair with their hands placed on a pillow.
Participants may have an electroencephalography. A cap with small disc electrodes will be placed on the scalp.
|Condition or disease|
The purpose of this protocol is to improve understanding of the neurophysiological mechanisms that underlie the phenomenon of surround inhibition in the human motor cortex. It is known that patients with focal hand dystonia have abnormal motor surround inhibition. However, the physiology of this phenomenon still remains unclear. The 2 sub-studies proposed under this protocol will integrate several neurophysiological techniques to explore different aspects of motor surround inhibition. The objectives of sub-study 1 are (a) to identify the EEG correlate of motor SI (b) to determine the relationship between short interval intracortical inhibition (SICI) and SI, both of which are compromised in patients with FHD and (c) to determine if there is an oscillatory frequency band that is relevant for SI. The results from this sub-study will shed light on the inhibitory mechanisms that are critical for motor SI. Sub-study 2 is aimed at determining the influence of parietal conditioning on motor surround inhibition. If conditioning the parietal cortex enhances SI, we can conclude that the parieto-motor inhibitory network may be involved in motor SI and that this network could be affected in focal hand dystonia.
We intend to study up to 65 healthy volunteers in total. Up to 30 participants will be recruited for sub-study 1 and 35 for sub-study 2.
Sub-study 1: This will be an exploratory study. Participants will perform an auditory cued index finger movement task and motor evoked potentials will be elicited by stimulating the motor hotspot of a surround muscle using transcranial magnetic stimulation (TMS). EEG will be recorded continuously. Single or paired TMS pulses (with postero-anterior or antero-posterior current) will be delivered either while the subject is at rest or at movement onset. TMS-evoked potentials (TEPs) will be obtained by time-locked averaging of all the trials in each condition. The amplitudes of the different peaks of the TEP will be compared across conditions which may be correlated with the degree of SI or SICI. The components of the TEP that are most relevant to motor SI will thus be identified.
Sub-study 2: This will be a hypothesis-driven study. Our primary hypothesis is that parietal conditioning will influence motor SI in healthy volunteers. Participants will perform an auditory cued index finger movement task and motor evoked potentials will be elicited by stimulating the motor hotspot of a surround muscle using transcranial magnetic stimulation. Two coils, one positioned over the motor cortex and the other over an inhibitory region of the inferior parietal lobule, will deliver TMS pulses at a fixed inter-stimulus interval. The pulses will be delivered either while the subject is at rest or at movement onset. The ratio of mean MEP amplitude obtained with parietal conditioning to that obtained with motor cortex stimulation alone at movement onset will reveal any parieto-motor influence on SI.
For sub-study 1, our outcome measures will be (1) amplitudes of the different TEP peaks (2) degree of surround inhibition and short interval intracortical inhibition (3) correlation between them and relevant peak amplitudes (4) power and cortico-cortical coherence at different frequency bands.
MEP amplitude will be the primary outcome measure in sub-study 2.
|Study Type :||Observational|
|Actual Enrollment :||39 participants|
|Official Title:||Detailed Evaluation of the Neurophysiology of Surround Inhibition in the Human Motor Cortex|
|Study Start Date :||January 11, 2017|
|Actual Primary Completion Date :||May 17, 2019|
|Actual Study Completion Date :||May 17, 2019|
- For substudy 1, the outcome measures are amplitudes of the different peaks of the TMS-evoked potential, degree of motor surround inhibition and degree of short latency intracortical inhibition. [ Time Frame: Ongoing ]
- For substudy 2, the primary outcome measure is the amplitude of motor evoked potential. [ Time Frame: Ongoing ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03018262
|United States, Maryland|
|National Institutes of Health Clinical Center|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Mark Hallett, M.D.||National Institute of Neurological Disorders and Stroke (NINDS)|